Argent Biopharma Issues New Employee Incentive Options
Company Announcements

Argent Biopharma Issues New Employee Incentive Options

Mgc Pharmaceuticals Ltd. (AU:RGT) has released an update.

Argent Biopharma Limited has announced the issue of 131,000 unlisted options expiring on April 1, 2029, with each option priced at A$0.70, set to be issued on April 26, 2024. These equity securities are a part of an employee incentive scheme and are not intended to be quoted on the ASX.

For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskArgent BioPharma Unveils Preliminary Financials
TipRanks UK Auto-Generated NewsdeskArgent BioPharma Schedules Shareholder Meeting
TipRanks UK Auto-Generated NewsdeskArgent BioPharma Pioneers Advanced Medical Treatments
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!